Daniel Geffken
@danielgeffken
Executive Officer
Building Lysosomal Therapeutics, Inc. as Executive Officer
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Lysosomal Therapeutics, Inc. was founded in 2011 and has no closure on record.
Named alongside
At Lysosomal Therapeutics, Inc.
- Bernard DavitianDirector
- Bruce BoothDirector
- Bruce L BoothDirector
- Carole E. NuechterleinDirector
- Carole NeuchterleinDirector
- Carole NuechterleinDirector
- Clay E. ThorpDirector
- Clay ThorpDirector
- Anthony GiovinazzoDirector
- Daniel E. GeffkenExecutive Officer
- Daniel T. GeffkenExecutive Officer
- ELLIOT GOLDSTEINExecutive Officer, Director
- EUGENE MINHO WILLIAMSDirector
- Eugene T. WilliamsDirector
- Eugene WilliamsExecutive Officer, Director
- Gail M. FarfelExecutive Officer
- Gregg BeloffDirector
- Hannah CravenDirector
- Jin KimExecutive Officer, Director, Promoter
- Laurens GoffExecutive Officer, Director, Promoter
At Vedantra Pharmaceuticals, Inc.
- Annette MatthiesMs. Matthies is the Chief Business Officer of the Issuer.
- Assaf SegalDirector
- Carol AsheDirector
- Christopher HaqqExecutive Officer
- Daphne KarydasDirector
- Frank HaluskaDirector
- Isaac BlechDirector
- Isaac KohlbergDirector
Contribution
Daniel's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Lysosomal Therapeutics, Inc.Executive Officer · Biotechnology · CAMBRIDGE, United States · Founded 2011
- Vedantra Pharmaceuticals, Inc.Pharmaceutical Preparations; formerly Vedantra Pharmaceuticals, Inc.; filing with the SEC since 2012Mr. Geffken is the Chief Financial Officer of the Issuer. · Biotechnology · Cambridge, United States
- SG DAN Holdings LLCDirector · Other · New York, United States · Founded 2018
- WINDTREE THERAPEUTICS INC /DE/Director · Biotechnology · WARRINGTON, United States
- ProMIS Neurosciences Inc.Pharmaceutical Preparations; formerly AMORFIX LIFE SCIENCES LTD; listed on Nasdaq as PMN; filing with the SEC since 2006Executive Officer · Biotechnology · TORONTO